Citrate is the primary active ingredient.
Adjuvant treatment of hormone receptorpositive breast cancer in women.
Treatment of hormone receptorpositive metastatic breast cancer in women.
Prevention of breast cancer in highrisk women (chemoprevention).
Tamoxifen Citrate Tablets Ip 10 Mg (Tamoxifen) is a selective estrogen receptor modulator (SERM). It works by blocking the effects of estrogen on breast cancer cells, thereby inhibiting their growth and proliferation. It acts as an estrogen antagonist in breast tissue but can have agonist effects in other tissues, such as the uterus and bone.
Store at room temperature (20-25°C), away from moisture and direct sunlight. Keep out of reach of children.
Dosage and duration of treatment vary depending on the specific indication and patient factors. Always follow your doctor's prescribed dosage and regimen.
It is typically administered orally, once or twice daily.
Hot flashes
Vaginal bleeding or discharge
Nausea
Vomiting
Weight changes
Fatigue
Hair thinning or loss
Increased risk of blood clots (thromboembolism)
Increased risk of uterine cancer
Increased risk of cataracts
Changes in liver function tests
Limit alcohol consumption as it can increase the risk of some side effects.
Caution advised if experiencing drowsiness or dizziness.
Tamoxifen is contraindicated in pregnancy and breastfeeding women due to potential harm to the fetus and infant. Effective contraception is necessary.
Tamoxifen is not indicated for use in children.
Renal impairment may require dosage adjustment. Consult your physician.
Hepatic impairment may require dosage adjustment. Consult your physician.
Please consult your doctor or pharmacist for detailed information and references. Refer to the official medication leaflet provided with your prescription.
